New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2013
16:30 EDTCWH, ZGNX, PZZA, GWRE, AH, AAPLOn The Fly: Closing Wrap
Stocks on Wall Street were higher after pending home sales data lifted the averages. The averages reversed off their early session lows quickly and the upward momentum carried on throughout the day, leading to a close near multi-year highs for the Dow and the S&P... ECONOMIC EVENTS: In the U.S., durable goods orders fell 5.2% in January, versus the expected decline of 4.8%. When transportation items are removed from the data, orders were up 1.9%, versus an expected increase of 0.2%. Pending home sales increased 4.5% in January from the prior month, versus an expected increase of 1.9%... COMPANY NEWS: Apple (AAPL) held its annual shareholders meeting amidst speculation that the company may announce measures to address its considerable cash holdings. However, CEO Tim Cook went no further than saying the company is having "very, very active" talks regarding what to do with its cash. Apple shares bounced around during the meeting, ending the day down $4.40, or 0.98%, at $444.57... MAJOR MOVERS: Among notable gainers was Guidewire (GWRE), up $5.22, or 16.56%, to $36.75 after the company reported earnings that beat estimates and Pacific Crest raised its price target on shares to $40 from $36. Also higher were shares of Zogenix (ZGNX), up 49c, or 40.5%, to $1.70 after the company said it is unlikely to receive an action letter from the FDA, which analysts said could be a positive. Among noteworthy losers was Accretive Health (AH), down $2.54, or 20.97%, to $9.57 after postponing its Q4 earnings report due to an accounting review. Also lower were shares of Papa John's (PZZA), down $5.18, or 9.14%, to $51.47 after the company disclosed last night that it was restating its FY09, FY10, and FY11 earnings after reassessing the accounting of its joint venture agreements. Another decliner was CommonWealth REIT (CWH), down $1.89, or 7.75%, to $22.51 as the company reiterated its intention to pursue a common share offering. Investors Corvex and Related, which yesterday said they were prepared to offer $25 per share for the company, are now reportedly ready to offer $27 per share if the planned offering is canceled and the company agrees to hold talks... INDICES: The Dow was up 175.24, or 1.26%, to 14,075.37; the Nasdaq was up 32.61, or 1.04%, to 3,162.26; and the S&P 500 was up 19.05, or 1.27%, to 1,515.99.
News For AAPL;GWRE;ZGNX;AH;PZZA;CWH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 >>
September 30, 2015
08:56 EDTGWREGuidewire selected by Pekin Insurance to enhance system processing
Subscribe for More Information
08:07 EDTZGNXZogenix reports positive top-line results from Relday Phase 1b clinical trial
Zogenix announced positive top-line pharmacokinetic results from its Phase 1b multi-dose clinical trial of Relday, a proprietary, once-monthly subcutaneous investigational formulation of risperidone for the treatment of schizophrenia. If approved, Relday has the potential to be the first subcutaneous antipsychotic product that achieves therapeutic drug levels on the first day of administration, allows for once-monthly dosing and does not require reconstitution. Zogenix has retained Locust Walk Partners of Cambridge, MA, a transaction advisory firm for life sciences companies, to provide transaction advisory and support services for Relday, and has now initiated efforts to secure a global strategic development and commercialization partner for Relday. The Phase 1b multi-dose parallel group clinical trial enrolled 60 subjects comprised of three cohorts of patients receiving four monthly injections of Relday, at dose levels of either 60, 90 or 120 mg of risperidone per month. A fourth cohort received five bi-weekly intramuscular injections of Risperdal Consta. Risperdal Consta requires oral supplementation for the first three weeks following dosing initiation, and requires at least four doses to reach steady state. The results for Relday demonstrated that risperidone plasma concentrations in the therapeutic range were achieved on the first day of dosing, reached steady state levels following the second dose and consistently maintained therapeutic levels throughout the four-month period. In addition, dose proportionality was confirmed across the dose range intended for clinical practice (60 to 120 mg). Relday was generally safe and well-tolerated, with results consistent with the profile of risperidone and the Company's previous Phase 1 single-dose clinical trial.
06:04 EDTAAPLApple volatility elevated
Subscribe for More Information
06:01 EDTAAPLAnalog Devices upgraded to Buy from Neutral at Citi
Subscribe for More Information
05:16 EDTAAPLApple Music, iTunes Movies, iBooks now available in China
Subscribe for More Information
September 29, 2015
20:07 EDTAAPLApple iPhone 6s Plus costs roughly $236 to manufacture, Re/code says
Subscribe for More Information
16:01 EDTAAPLApple October weekly volatility elevated at 50, October at 44
Subscribe for More Information
16:00 EDTAAPLOptions Update; September 29, 2015
Subscribe for More Information
12:44 EDTAAPLApple says OS X El Capitan available Wednesday
Subscribe for More Information
12:29 EDTAAPLGoogle announces Nexus 6P smartphone
The Nexus 6P features an all-metal body and a 5.7-inch AMOLED display. The phone is manufactured in cooperation with Huawei, and includes a USB-C port that can charge the device twice as fast as an Apple (AAPL) iPhone 6 Plus, according to Google (GOOG). The 6P uses a 12.3 megapixel rear-facing Sony (SNE) camera, as well as a 5 megapixel front-facing camera. The phone also includes Nexus Imprint, an advanced fingerprint authentication technology. Google executives are speaking at the company's Nexus 2015 event.
11:23 EDTAAPLNeuroMetrix launches Android app for Quell
Subscribe for More Information
10:00 EDTAAPLOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:35 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:29 EDTAAPLApple updates privacy site to explain how personal information is handled
Apple updated the privacy section of its website, and CEO Tim Cook says this is aimed at explaining how the company handles each user's personal information, "what we do and don't collect." In an introduction letter for the new site expansion, Cook states "Security and privacy are fundamental to the design of all our hardware, software, and services, including iCloud and new services like Apple Pay. And we continue to make improvements. Two-step verification, which we encourage all our customers to use, in addition to protecting your Apple ID account information, now also protects all of the data you store and keep up to date with iCloud. We believe in telling you up front exactly what's going to happen to your personal information and asking for your permission before you share it with us. And if you change your mind later, we make it easy to stop sharing with us. Every Apple product is designed around those principles. When we do ask to use your data, it's to provide you with a better user experience. We're publishing this website to explain how we handle your personal information, what we do and don't collect, and why. We're going to make sure you get updates here about privacy at Apple at least once a year and whenever there are significant changes to our policies." Reference Link
08:28 EDTAAPLApple data may not be good indicator of demand, says Bernstein
After Apple announced that the sales of its iPhone 6S and iPhone 6S+ exceeded 13M units over the first weekend of availability, Bernstein says the figure is "strong versus history." However, the firm thinks that the strength could have been caused by improved supply of iPhones, rather than increased demand for them. The firm says it's "hard to conclude" whether 6S sales Q4/Q1. will exceed 2014 levels. Bernstein keeps a $135 price target and Outperform rating on Apple.
06:56 EDTAAPLApple markets privacy, criticizes Google, Verge says
Apple (AAPL) continues to strengthen its credentials as a company caring about privacy, having updated its privacy site, adding in details on how data is collected for new iOS 9 features, such as the News app, the Verge reports. The site includes a letter from CEO Tim Cook, the report says. The company's description of Maps privacy may be a thinly-veiled criticism of Google (GOOG), the Verge says. Reference Link
06:31 EDTAAPLApple, Samsung agree to court-supervised mediation in patent dispute
According to a court filing, Apple (AAPL) and Samsung (SSNLF) have agreed to participate in court-supervised mediation of their years-long dispute over patents. "Pursuant to the September 18, 2015, Case Management Order, the parties jointly submit this update on alternative dispute resolution. The parties are willing to mediate with Judge Spero with a settlement conference deadline of November 15, 2015, and are conferring on scheduling," the court document says. Reference Link
06:19 EDTAAPLIcahn a little longer than short the market, CNBC reports
Carl Icahn is positioned as a "little longer than short" the market, CNBC's Scott Wapner reports following the release of the billionaire's "Danger Ahead" movie. Icahn is keeping as is his long position in Apple (AAPL), Wapner added. The famed investor owns Freeport McMoRan (FCX) as a play on copper prices recovering over the long term, the reported noted after speaking with Icahn on the phone. Icahn last night raised his stake in Cheniere Energy (LNG).
06:13 EDTAAPLIcahn says sticking with Apple position, CNBC reports
Subscribe for More Information
05:56 EDTAAPLApple's iPhone 6s expected to have strong sales in Q4, DigiTimes reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use